The Use of Sofosbuvir for the Treatment of Recurrent Hepatitis C After Liver Transplantation

Transplantologiya
doi 10.23873/2074-0506-2017-9-1-13-22
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IPO Association of Transplantologists

Related search

Ledipasvir and Sofosbuvir for Recurrent Hepatitis C After Liver Transplantation

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2016English

Sofosbuvir Plus Ledipasvir for Recurrent Hepatitis C in Liver Transplant Recipients

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Hepatitis C Virus Recurrence After Liver Transplantation

Gut
Gastroenterology
1999English

Development of Highly Aggressive Mantle Cell Lymphoma After Sofosbuvir Treatment of Hepatitis C

Blood Cancer Journal
OncologyHematology
2016English

New and Evolving Management Paradigms for Hepatitis C After Liver Transplantation

Current Hepatitis Reports
2011English

Recurrent Hepatitis C Virus (Genotype 4) Infection After Living Donor Liver Transplantation: Risk Factors and Outcome

Journal of Liver
2014English

Hepatitis C and Liver Transplantation

2012English

Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2015English

Very Late Relapse of Hepatitis C Virus Infection Immediately After Liver Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy